Aurelio has been a researcher at the Medical Technology Research Group since 2018 where his work focuses on pharmaceutical economics and policy. He has collaborated on numerous projects related to health technology assessment, orphan drugs regulation, personalised medicine and intellectual property rights in the pharmaceutical market. He is an expert in stakeholder analysis and systematic literature searches and reviews.
He holds an MSc in International Health Policy from the LSE. As part of his MSc dissertation he undertook a systematic literature review on the impact of sin taxes in Latin America, which has been published on a leading peer-reviewed journal. He has also contributed on the development of two LSE Consulting white papers, related to predictive analytics techniques and big data in healthcare and access to personalised oncology in Europe.